
This study aimed to discover to what extent ethical issues are considered in the reimbursement decision process based on health technology assessment zzso in Korea, especially for zzso zzso Public summary documents zzso published by the Health Insurance Review and Assessment Service zzso were analyzed for empirical and zzso zzso For external comparison, zzso presented by corresponding institutions of Australia and the United Kingdom were zzso Furthermore, the opinions of eight expert zzso were obtained regarding the accountability of the evidence in zzso Among 7 zzso drugs, there were differences in the final decisions and empirical factors considered, such as selected zzso and interpretation of evidence between the zzso from the three zzso From an ethical viewpoint, the following matters were deficient in the zzso decision-making process for zzso drugs: clear and reasonable standards; identifying and evaluating ethical values; and public accountability for zzso about decisions and due zzso 

